Gerald McMahon

Gerald McMahon served as President at Sugen, Inc. from 1993 to 2004.
From 2004 to 2012, held the position of Non-Executive Chairman at Poniard Pharmaceuticals, Inc. Between 2010 and 2012, was Senior VP-Oncology Innovative Medicines Unit at MedImmune LLC.
From 2011 to 2016, worked as Independent Director at Oncotelic Therapeutics, Inc. Served as Director at Celldex Therapeutics, Inc. from 2016 to 2018.
Held roles of President, Chief Executive Officer & Director at Kolltan Pharmaceuticals, Inc., Harpoon Therapeutics, Inc. from 2016 to 2021, and STORM Therapeutics Ltd. Also held positions as Director at Trellis Bioscience, Inc., Senior Vice President-Research & Development at Pharmacia Corp., Staff Investigator at Massachusetts Institute of Technology, and Venture Partner at Bay City Capital LLC.
Education includes undergraduate and doctorate degrees from Rensselaer Polytechnic Institute, with the doctorate conferred in 1980.